<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20800" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Body Dysmorphic Disorder</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nicewicz</surname>
            <given-names>Holly R.</given-names>
          </name>
          <aff>University Hospital and Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Torrico</surname>
            <given-names>Tyler J.</given-names>
          </name>
          <aff>Consilient Interventional Psychiatry</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Boutrouille</surname>
            <given-names>Jacqueline F.</given-names>
          </name>
          <aff>NOVA university</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Holly Nicewicz declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Tyler Torrico declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jacqueline Boutrouille declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>20</day>
          <month>1</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20800.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Body dysmorphic disorder (BDD) is a psychiatric condition defined in the <italic toggle="yes">American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Text Revision (DSM-5-TR)</italic> as a preoccupation with a perceived defect or flaw in one&#x02019;s physical appearance when, in fact, they appear normal. Often underrecognized, BDD is a prevalent psychiatric condition characterized by an all-consuming focus on perceived physical imperfections, leading to distressing repetitive actions and, at times, suicidal behavior and ideation. Individuals with BDD often seek unnecessary surgical interventions. This topic offers guidance on recognizing common BDD indicators, implementing effective screening tools, and utilizing evidence-based approaches for evaluation and treatment. This topic also addresses the importance of interprofessional recognition of symptoms and collaboration in delivering optimal patient care.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the <italic toggle="yes">DSM-5-TR</italic> diagnostic criteria of body dysmorphic disorder.</p></list-item><list-item><p>Implement systematic screening protocols in clinical settings to identify individuals at risk of body dysmorphic disorder, especially among those seeking cosmetic or dermatological procedures.</p></list-item><list-item><p>Implement evidence-based interventions, such as cognitive-behavioral therapy (CBT) and medication, as part of a comprehensive treatment plan for patients diagnosed with body dysmorphic disorder.</p></list-item><list-item><p>Coordinate care across various healthcare disciplines to ensure a holistic approach to diagnosing and managing body dysmorphic disorder, along with addressing its impact on patients' overall well-being.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20800&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20800">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20800.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Body dysmorphic disorder (BDD) is a psychiatric condition defined in the&#x000a0;<italic toggle="yes">American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Text Revision (DSM-5-TR)</italic>&#x000a0;as a preoccupation with a perceived defect or flaw in one&#x02019;s physical appearance when, in fact, they appear normal. Often underrecognized, BDD is a prevalent psychiatric condition characterized by an all-consuming focus on perceived physical imperfections, leading to distressing repetitive actions and, at times, suicidal behavior and ideation. Individuals with BDD often seek unnecessary surgical interventions.&#x000a0;</p>
        <p>The<italic toggle="yes"> DSM</italic> has recategorized BDD since its introduction in 1980. Initially described as an atypical somatoform disorder and then a distinct somatoform disorder in 1987, BDD now falls in the <italic toggle="yes">DSM-5-TR</italic> under the spectrum of obsessive-compulsive and related disorders.<xref ref-type="bibr" rid="article-20800.r1">[1]</xref>&#x000a0;Patients affected by BDD have a preoccupation with a perceived defect or flaw in their physical appearance that is either not noticeable or only slightly observable by others. Symptoms cause marked impairment in social, academic, occupational, or other areas of functioning. To meet diagnostic criteria, patients must engage in repetitive behaviors, such as excessive mirror checking, camouflaging (ie, covering up the defect with makeup or clothing), skin picking, excessive grooming, excessive weight lifting, or pervasive mental acts such as comparing one&#x02019;s appearance to others. These behaviors are time-consuming, difficult to control, and distressing to the individual.<xref ref-type="bibr" rid="article-20800.r2">[2]</xref>&#x000a0;Body dysmorphic disorder is underrecognized, and affected patients visit dermatology and plastic surgery clinics to repair their perceived defects.&#x000a0;Understanding BDD's features and diagnostic criteria across all healthcare specialties helps increase awareness and recognition of the condition.<xref ref-type="bibr" rid="article-20800.r3">[3]</xref>&#x000a0;</p>
        <p>In 1891, Enrico Morselli, an Italian psychiatrist, coined the term dysmorphophobia, derived from the Greek word <italic toggle="yes">dysmorfia</italic>, meaning ugliness, to describe people who perceive themselves as flawed but have no apparent physical deformities. Pierre Janet, a French psychologist, discussed cases of this condition and labeled it "l'obsession de la honte du corps," which translates to "obsessions of shame of the body." Sigmund Freud also detailed a case known as "Wolf Man," a man obsessed with his nose, which caused him significant social distress.</p>
      </sec>
      <sec id="article-20800.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Body dysmorphic disorder develops from psychological, social, and biological factors. High-quality studies investigating the pathogenesis of BDD are limited and small. Neuroimaging findings discovered in studies could be etiologic findings or sequelae from the disease process. One preliminary candidate gene study of 57 subjects with BDD matched with 58 healthy controls demonstrated that the <italic toggle="yes">GABA-A-gamma-2 (5q31.1-q33.2)</italic> receptor gene occurred more frequently in subjects with BDD than in the controls.&#x000a0;<xref ref-type="bibr" rid="article-20800.r4">[4]</xref>&#x000a0;The heritability of BDD, investigated through twin studies, revealed an estimated 43% genetic contribution for BDD.<xref ref-type="bibr" rid="article-20800.r5">[5]</xref>&#x000a0;The remaining contributors are psychological and environmental. A history of physical or sexual abuse may contribute to the development of BDD.&#x000a0;<xref ref-type="bibr" rid="article-20800.r6">[6]</xref>&#x000a0;Individuals who report lower levels of perceived parental care in childhood or a history of parental neglect have a higher prevalence of BDD than controls.&#x000a0;<xref ref-type="bibr" rid="article-20800.r7">[7]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-20800.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>BDD is reported globally in all ages, in both males and females. The overall global prevalence is 2% to 3%, with a higher incidence in females than males.<xref ref-type="bibr" rid="article-20800.r8">[8]</xref><xref ref-type="bibr" rid="article-20800.r3">[3]</xref><xref ref-type="bibr" rid="article-20800.r9">[9]</xref><xref ref-type="bibr" rid="article-20800.r10">[10]</xref>&#x000a0;Community studies conducted in multiple countries, including the United States, have estimated the prevalence to be approximately 2% to 3% in adults, 2% to 5% in adolescents, and 3% among higher education students.<xref ref-type="bibr" rid="article-20800.r10">[10]</xref><xref ref-type="bibr" rid="article-20800.r11">[11]</xref><xref ref-type="bibr" rid="article-20800.r12">[12]</xref></p>
        <p>Requests for cosmetic surgical procedures are common for patients with BDD. An estimated 13% of patients in general cosmetic surgery clinics have BDD.<xref ref-type="bibr" rid="article-20800.r3">[3]</xref>&#x000a0;The estimated prevalence of BDD in patients pursuing rhinoplasty is 20%.<xref ref-type="bibr" rid="article-20800.r3">[3]</xref>&#x000a0;Approximately 11% of patients seeking orthognathic (jaw) surgery are affected by BDD.<xref ref-type="bibr" rid="article-20800.r3">[3]</xref>&#x000a0;Between 5% to 10% of patients requesting orthodontic dentistry treatment are also affected.<xref ref-type="bibr" rid="article-20800.r3">[3]</xref>&#x000a0;Individuals with BDD may engage in medical tourism, which involves patients seeking medical treatments and surgeries abroad.<xref ref-type="bibr" rid="article-20800.r13">[13]</xref></p>
        <p>BDD is often a comorbid psychiatric illness among those diagnosed with anxiety, depression, psychotic, or bipolar spectrum disorders. For those with any of these comorbid psychiatric illnesses, the inpatient prevalence of BDD is estimated at 7%,&#x000a0;while the outpatient prevalence is approximately 6%.<xref ref-type="bibr" rid="article-20800.r3">[3]</xref>&#x000a0;However, individuals with obsessive-compulsive disorder (OCD) or an eating disorder may have a higher prevalence of comorbid BDD.<xref ref-type="bibr" rid="article-20800.r8">[8]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-20800.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The current understanding of the pathophysiology of BDD is limited. No specific biomarkers are currently available. Some biological findings have been identified as potential clues to identify the illness. Overlapping features discovered from studies of OCD have also provided some insight. Neuroanatomic findings for BDD are inconsistent.<xref ref-type="bibr" rid="article-20800.r14">[14]</xref>&#x000a0;Findings of magnetic resonance studies are increased total white matter volume, a leftward shift in caudate volume asymmetry,&#x000a0;smaller orbitofrontal cortex, and anterior cingulate volume combined with larger thalamic volumes in patients with BDD compared to controls.<xref ref-type="bibr" rid="article-20800.r15">[15]</xref><xref ref-type="bibr" rid="article-20800.r16">[16]</xref>&#x000a0;White matter fiber disorganization in tracts connecting visual processing and emotion and memory processing could explain the severity level of delusional preoccupation, an example of poor insight with misperceived appearance defects.<xref ref-type="bibr" rid="article-20800.r17">[17]</xref>&#x000a0;</p>
        <p>Results from both functional magnetic resonance imaging (fMRI) and visual processing tasks (Rey-Osterrieth Complex Figure test, inverted faces task, embedded figures task) reveal local or detail-oriented visual processing is enhanced while holistic or global visual processing is diminished in patients with BDD.<xref ref-type="bibr" rid="article-20800.r18">[18]</xref>)<xref ref-type="bibr" rid="article-20800.r19">[19]</xref><xref ref-type="bibr" rid="article-20800.r20">[20]</xref>&#x000a0;Patients with BDD asked to view certain faces while undergoing a fMRI revealed abnormal patterns of hyperactivity in the left orbitofrontal cortex and bilateral head of the caudate, combined with hypoactivity in the occipital cortex, a visual processing area.<xref ref-type="bibr" rid="article-20800.r21">[21]</xref>&#x000a0;One additional fMRI study found patients with BDD had hypoactivity in the dorsal visual and parietal networks compared to healthy controls.<xref ref-type="bibr" rid="article-20800.r22">[22]</xref>&#x000a0;</p>
        <p>Subjects with BDD have a decreased ability to recognize the emotions of others through facial expressions, an emotional processing deficit. One study found that patients with BDD are likelier to misinterpret neutral facial expressions in photographs as angry.<xref ref-type="bibr" rid="article-20800.r23">[23]</xref>&#x000a0;Executive function may also be impaired. Specific areas of difficulty are response inhibition, planning, and decision-making.<xref ref-type="bibr" rid="article-20800.r24">[24]</xref><xref ref-type="bibr" rid="article-20800.r25">[25]</xref>&#x000a0;Deficits in executive function combined with neuroimaging findings suggest that subjects with BDD have frontal lobe dysfunction compared to healthy controls.<xref ref-type="bibr" rid="article-20800.r26">[26]</xref></p>
      </sec>
      <sec id="article-20800.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with BDD have thoughts focused on personal or physical defects that are either very minor or do not exist. These pervasive thoughts are challenging to control and consume an average of 3 to 8 hours daily.<xref ref-type="bibr" rid="article-20800.r2">[2]</xref>&#x000a0;Some patients are excessively preoccupied with a single body area. In contrast, others develop preoccupations with multiple body areas, averaging between 5 to 7 different areas of concern.<xref ref-type="bibr" rid="article-20800.r26">[26]</xref>&#x000a0;Any physical feature is a potential perceived defect for a patient affected by BDD. The most common concerns revolve around the patient's skin, hair, nose, stomach, breasts, and eyes.<xref ref-type="bibr" rid="article-20800.r8">[8]</xref><xref ref-type="bibr" rid="article-20800.r26">[26]</xref><xref ref-type="bibr" rid="article-20800.r26">[26]</xref><xref ref-type="bibr" rid="article-20800.r8">[8]</xref>&#x000a0;Males are more commonly preoccupied with genital size and balding, while females are more likely to focus on areas with body fat, like the breasts, legs, hips, buttocks, and waist.<xref ref-type="bibr" rid="article-20800.r26">[26]</xref>&#x000a0;</p>
        <p>An all-consuming belief that one appears ugly, deformed, or defective causes emotional turmoil. Repetitive behaviors, or compulsions and rituals, attempt to relieve the psychological stress related to the pervasive thoughts. All patients with BDD display repetitive behaviors at some time during their illness.&#x000a0;Common rituals include hiding, camouflaging, mirror checking, excessive grooming, clothes changing, excessive exercise, inspecting, and obtaining reassurance about the concerning body part. Occasionally, the ritualistic behaviors may not be observable by others and are entirely mental rituals like comparing, counting, and self-assuring.</p>
        <p>Tangible findings on the mental status examination are variable. Skin or hair-picking wounds may be visible beyond the perceived deficit and camouflaging efforts. The practitioner may witness compulsive behaviors. Affected patients may actively pick their skin, comb their hair, cover the worrisome part of their body, count, or self-reassure.</p>
        <p>Although the mental status examination is typically only performed in psychiatric settings, various specialties perform the physical examination. The provider distinguishes between a perceived flaw and an actual physical defect on examination. However, the physical examination should focus on areas where the patient has vocalized their perceived deficit.</p>
      </sec>
      <sec id="article-20800.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>BDD&#x000a0;is an underrecognized medical. Clues to the presence of BDD are treatment-resistant depression and anxiety, a history of unsuccessful cosmetic procedures, or thinking others are making fun of them. Substance use disorder is primarily intended to alleviate distress and avoid social situations, and the pursuit of unnecessary cosmetic procedures should raise clinical suspicion. Screening in mental health, substance abuse, or any setting where cosmetic procedures occur could improve recognition. The self-report Body Image Disturbance or the Body Dysmorphic Disorder Questionnaires are available.<xref ref-type="bibr" rid="article-20800.r27">[27]</xref><xref ref-type="bibr" rid="article-20800.r28">[28]</xref>&#x000a0;Directly ask patients about their symptoms. They will often not divulge them voluntarily.</p>
        <p>Individuals with suspected BDD warrant a referral for a psychiatric evaluation. The goals of the initial psychiatric evaluation are to build a relationship of trust, collect historical information in detail related to the presenting problem, and conduct a mental status examination. Psychiatric interview questions should be approached with sensitivity and in a non-judgmental manner. Establishing rapport with a patient affected by BDD is essential, particularly for those with absent insight who may be hesitant to share their history or participate in their treatment plan. The psychiatric evaluation should include focused interview questions that successfully address each of the <italic toggle="yes">DSM-5-TR</italic> diagnostic criteria for BDD.&#x000a0;</p>
        <p>
<bold>Body Dysmorphic Disorder <italic toggle="yes">DSM-5-TR</italic> Criteria</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Affected patients experience preoccupation with one or more perceived defects or flaws in physical appearance that are not observable or only slightly observable to others.</p>
          </list-item>
          <list-item>
            <p>Affected patients perform repetitive behaviors.</p>
          </list-item>
          <list-item>
            <p>The thought preoccupation causes clinically significant distress or impairment in a major life area of functioning.</p>
          </list-item>
          <list-item>
            <p>An eating disorder does not better explain the thought preoccupation.</p>
          </list-item>
        </list>
        <p>If the patient's primary belief is that their muscles or physique is too small, the diagnosis requires a specifier, and "body dysmorphic disorder with muscle dysmorphia" becomes the diagnosis. Patients who also experience panic attacks due to BDD are diagnosed with "body dysmorphic disorder with panic attacks."</p>
        <p>Determining the patient's degree of insight into their illness helps to determine treatment course and expectations. Those with good or fair insight recognize that their beliefs about their body are not valid or at least probably not valid. Patients with poor insight believe that their thoughts are likely true. Those with absent insight or delusional beliefs hold firm to their beliefs regardless of what others think.</p>
        <p>Laboratory and radiographic imaging are not typically necessary unless the patient has engaged in extreme behaviors that raise concern for their physical health.&#x000a0;</p>
      </sec>
      <sec id="article-20800.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Patients often seek cosmetic surgical solutions for their perceived physical defects. Providing surgical solutions is not effective. The combination of medications and cognitive behavioral therapy can be effective. Clomipramine and high doses of selective serotonin reuptake inhibitors (SSRI) are first-line pharmacotherapeutic interventions selected based on our knowledge of treating obsessive-compulsive disorder.<xref ref-type="bibr" rid="article-20800.r29">[29]</xref><xref ref-type="bibr" rid="article-20800.r30">[30]</xref>&#x000a0;No head-to-head trials have compared the effectiveness of pharmacotherapy with cognitive behavioral therapy (CBT).</p>
        <p>
<bold>Psychotherapeutic Interventions</bold>
</p>
        <p>Establishing a therapeutic rapport is the cornerstone of treating BDD. Although supportive psychotherapy is unlikely to reduce symptoms of BDD,&#x000a0;educating patients about their illness, being an active listener, and providing guidance on the treatments for BDD help to establish trust between the healthcare professional and the patient. This includes educating the patient about their illness, being an active listener, and providing guidance on the treatments for BDD. Patients will often direct the conversation towards how they perceive themself as ugly. Avoid directly focusing on the patient's looks. Instead, after identifying the patient's preoccupation, direct the interview to how this preoccupation impairs critical areas of their daily functioning.<xref ref-type="bibr" rid="article-20800.r31">[31]</xref>&#x000a0;Examples are psychological suffering, suicidal thoughts, avoiding social outings, impaired ability to maintain employment or perform well in school, and interpersonal conflicts. Finally, it is crucial to discourage cosmetic interventions, as these rarely resolve BDD symptoms and can cause an increased financial burden along with worsening symptoms.<xref ref-type="bibr" rid="article-20800.r32">[32]</xref>&#x000a0;&#x000a0;</p>
        <p>CBT is a primary intervention for treating BDD.<xref ref-type="bibr" rid="article-20800.r31">[31]</xref><xref ref-type="bibr" rid="article-20800.r33">[33]</xref>&#x000a0;Cognitive behavioral therapy directed specifically towards BDD is preferred. Cognitive behavioral therapy utilizes techniques to identify and correct distortive maladaptive beliefs, a core feature of BDD. Specific techniques include education, relaxation exercises, the development of coping skills, and stress management.<xref ref-type="bibr" rid="article-20800.r31">[31]</xref>&#x000a0;Although medication interventions are more widely available than access to skilled therapists, there is evidence that telehealth CBT is effective in BDD<xref ref-type="bibr" rid="article-20800.r34">[34]</xref>. These additional treatment routes may continue to improve patients' ability to access CBT services.</p>
        <p>In severe BDD, motivational interviewing may be a helpful tool in assisting a patient who is hesitant to engage in treatment.<xref ref-type="bibr" rid="article-20800.r35">[35]</xref>&#x000a0;</p>
        <p>
<bold>Psychotropic Medication Interventions</bold>
</p>
        <p>Because pharmacotherapy is still generally more widely available than psychotherapy, medication-based treatments for BDD are common. Despite none of the following medications having an FDA-labeled indication to treat BDD, there is evidence for their effectiveness to varying degrees. SSRIs are a superior treatment to a placebo.<xref ref-type="bibr" rid="article-20800.r36">[36]</xref>&#x000a0;SSRIs are generally well tolerated, making them a favorable choice. However, no evidence suggests that any individual SSRIs may be superior to others. Patients with BDD often require higher doses than those approved by the FDA.<xref ref-type="bibr" rid="article-20800.r37">[37]</xref> For this reason, fluoxetine, sertraline, and escitalopram are good choices.<xref ref-type="bibr" rid="article-20800.r30">[30]</xref>&#x000a0;Escitalopram may be a favorable SSRI in patients on multiple medications as it is the least likely SSRI to have drug-drug interactions. Citalopram is generally not recommended to treat BDD because the FDA dosing limit is too low to treat BDD effectively, and high-dose citalopram is associated with QT prolongation.<xref ref-type="bibr" rid="article-20800.r30">[30]</xref><xref ref-type="bibr" rid="article-20800.r38">[38]</xref><xref ref-type="bibr" rid="article-20800.r39">[39]</xref>&#x000a0;Paroxetine is generally not as well tolerated as other SSRIs.</p>
        <p>Patients who fail adequate SSRI trials can augment their SSRI therapy with clomipramine. Clomipramine is a tricyclic antidepressant (TCA) with an FDA-labeled indication to treat OCD. Based on randomized trial data,&#x000a0;clomipramine&#x000a0;is a reasonable adjunctive treatment consideration for BDD.<xref ref-type="bibr" rid="article-20800.r29">[29]</xref>&#x000a0;Tricyclic antidepressants have significant adverse effects compared to SSRIs. Clomipramine is generally considered a second-line treatment. Doses of clomipramine exceeding 250mg/d produce bothersome adverse effects. Monitor patients for serotonin syndrome and QT prolongation.<xref ref-type="bibr" rid="article-20800.r37">[37]</xref>&#x000a0;</p>
        <p>The current hypothesis is that continuous treatment with clomipramine and SSRIs alters serotonin turnover and neuropeptide expression patterns in the forebrain and midbrain circuits of patients with obsessive-compulsive disorder.<xref ref-type="bibr" rid="article-20800.r38">[38]</xref>&#x000a0;Clinically, these pharmacological treatments decrease body dysmorphic preoccupations and compulsive behaviors<xref ref-type="bibr" rid="article-20800.r40">[40]</xref>. Further, SSRIs and TCAs are known effective treatments for depressive and anxiety disorders, which are often present in patients with BDD.<xref ref-type="bibr" rid="article-20800.r37">[37]</xref>&#x000a0;</p>
        <p>There is limited evidence for recommending other pharmacological treatments to treat BDD. The addition of buspirone, a glutamate modulator (memantine), or a second-generation antipsychotic medication is a potential therapy to add to SSRIs.<xref ref-type="bibr" rid="article-20800.r41">[41]</xref><xref ref-type="bibr" rid="article-20800.r42">[42]</xref><xref ref-type="bibr" rid="article-20800.r43">[43]</xref><xref ref-type="bibr" rid="article-20800.r44">[44]</xref>&#x000a0;Monotherapy treatment with venlafaxine has shown some efficacy in a small number of patients.<xref ref-type="bibr" rid="article-20800.r45">[45]</xref><xref ref-type="bibr" rid="article-20800.r37">[37]</xref><xref ref-type="bibr" rid="article-20800.r40">[40]</xref>&#x000a0;Single cases reports of bupropion augmentation of SSRIs reported some benefit.<xref ref-type="bibr" rid="article-20800.r46">[46]</xref><xref ref-type="bibr" rid="article-20800.r47">[47]</xref>&#x000a0;Considering their potential adverse effects, reports of monoamine oxidase inhibitors use provide inadequate evidence to recommend their use in BDD.<xref ref-type="bibr" rid="article-20800.r37">[37]</xref></p>
        <p>Suicidal ideation and behavior are commonly associated with BDD; patients who have active suicidal ideation or recent suicidal behavior warrant inpatient hospitalization.</p>
      </sec>
      <sec id="article-20800.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Many symptoms of BDD are present in other psychiatric disorders, and psychiatric comorbidities are common in individuals with BDD. Because of this overlap, BDD is misdiagnosed and underrecognized.</p>
        <p>
<bold>Normal Behavior Appearance Concern</bold>
</p>
        <p>Most individuals have ranging concerns about their appearance, many of which are normal and do not cause pathological symptoms. Normal appearance concerns should not be considered BDD. In normal behavior, there is an absence of obsessive preoccupations, compulsive behaviors, and a lack of psychological distress or impairment of functioning.<xref ref-type="bibr" rid="article-20800.r35">[35]</xref>&#x000a0;</p>
        <p>
<bold>Obvious Bodily Defects</bold>
</p>
        <p>Some individuals are preoccupied with bodily defects that are visible to others. When all the other DSM-5-TR diagnostic criteria for BDD are satisfied in these cases, the <italic toggle="yes">DSM-5-TR</italic> diagnosis is "other specified obsessive-compulsive and related disorder (body dysmorphic-like disorder with actual flaws)." Additionally, BDD's repetitive, compulsive behaviors may result in obvious bodily defects, such as skin picking, leading to skin lesions or scars. Evaluate such patients for a comorbid excoriation (skin-picking) disorder.<xref ref-type="bibr" rid="article-20800.r35">[35]</xref>&#x000a0;</p>
        <p>
<bold>Skin Picking (Excoriation) Disorder</bold>
</p>
        <p>Similar to BDD, skin picking (excoriation) disorder also falls under the umbrella of obsessive-compulsive spectrum disorders. Although individuals with BDD may have skin-picking behaviors, the motivation behind the behavior in excoriation disorder is not to improve a perceived appearance deficit.<xref ref-type="bibr" rid="article-20800.r35">[35]</xref>&#x000a0;</p>
        <p>
<bold>Trichotillomania (Hair-pulling Disorder)</bold>
</p>
        <p>Trichotillomania, or hair-pulling disorder, falls under the umbrella of obsessive-compulsive spectrum disorders and describes those who have difficulty resisting an urge to control pulling their hair out. Individuals with compulsive hair-pulling behaviors with persistent attempts to improve a perceived bodily deficit should be diagnosed with BDD rather than trichotillomania.<xref ref-type="bibr" rid="article-20800.r35">[35]</xref>&#x000a0;</p>
        <p>
<bold>Isolated Dysmorphic Concern</bold>
</p>
        <p>When patients present with a perceived bodily dysmorphic concern without compulsive, repetitive, or ritual behaviors, they do not meet the diagnostic criteria for BDD. A common dysmorphic concern includes the emission of a body odor.<xref ref-type="bibr" rid="article-20800.r35">[35]</xref>&#x000a0;Isolated dysmorphic concerns are not a diagnostic entry in the <italic toggle="yes">DSM-5-TR</italic> or a code in ICD-11.&#x000a0;</p>
        <p>
<bold>Obsessive-Compulsive Disorder</bold>
</p>
        <p>Because BDD is under the umbrella of obsessive-compulsive spectrum disorders, obtaining diagnostic clarity between the two illnesses is essential.<xref ref-type="bibr" rid="article-20800.r48">[48]</xref>&#x000a0;Both present with obsessions that include intrusive thoughts or preoccupations, persisting for a significant amount of time. These intrusive thoughts impair social and occupational functioning. In both illnesses, the obsessions are difficult to control or resist and are commonly kept secret due to associated shame. The essential difference between obsessive-compulsive disorder and BDD is that in BDD, obsessive thoughts and repetitive behaviors focus on perceived flaws in physical appearance.<xref ref-type="bibr" rid="article-20800.r49">[49]</xref>&#x000a0;If patients meet the <italic toggle="yes">DSM-5-TR</italic> criteria for both BDD and OCD, they should be diagnosed with both appropriately.<xref ref-type="bibr" rid="article-20800.r50">[50]</xref>&#x000a0;</p>
        <p>
<bold>Gender Dysphoria</bold>
</p>
        <p>Gender dysphoria and BDD share similarities in that they both include a desire to change a feature of one's physical appearance. This desire results in clinical distress and impairment in social or occupational functioning. The physical appearance in gender dysphoria is focused on primary or secondary sex characteristics, with additional psychological distress from incongruency of the individuals expressed experienced gender.<xref ref-type="bibr" rid="article-20800.r51">[51]</xref></p>
        <p>
<bold>Eating Disorders</bold>
</p>
        <p>Individuals with anorexia nervosa, bulimia nervosa, and BDD suffer from a distorted body image. Both patients may use harmful behaviors to change their appearance, such as extreme dieting, compensatory behaviors after binge eating, and excessive exercise. Individuals who meet the <italic toggle="yes">DSM-5-TR</italic> criteria for an eating disorder and BDD are diagnosed with both. However, this occurs after thoroughly ensuring symptoms are not the result of BDD alone or the eating disorder alone.<xref ref-type="bibr" rid="article-20800.r35">[35]</xref>&#x000a0;</p>
        <p>
<bold>Major Depressive Disorder&#x000a0;</bold>
</p>
        <p>Many individuals with BDD suffer from comorbid major depressive disorder. Patients should be diagnosed with both when meeting the <italic toggle="yes">DSM-5-TR </italic>diagnostic criteria for both illnesses. Still, many patients who only meet the diagnostic criteria for BDD may suffer from symptoms of anhedonia, difficulties with concentration, guilt, depressed mood, sleep disturbances, and appetite changes.<xref ref-type="bibr" rid="article-20800.r35">[35]</xref></p>
        <p>
<bold>Social Anxiety Disorder</bold>
</p>
        <p>Due to the fear of being judged by their physical appearance, individuals with BDD may have increasingly reclusive behavior as their illness progresses. Social anxiety disorder (SAD) also presents with similar reclusiveness. The primary concern in SAD is fear of negative valuation of their behavior or speech content.<xref ref-type="bibr" rid="article-20800.r35">[35]</xref>&#x000a0;To differentiate these illnesses further, BDD presents with repetitive behaviors, while social anxiety does not. Patients who meet the <italic toggle="yes">DSM-5-TR</italic> diagnostic criteria for both illnesses should be diagnosed with both.&#x000a0;</p>
        <p>
<bold>Delusional Disorder</bold>
</p>
        <p>Individuals with severe BDD and poor insight into their illness may present with delusional beliefs about their physical appearance. In BDD, the thought preoccupation is not required to be delusional but can be simply an exaggeration of an actual minor blemish. Additionally, compulsive behaviors are not characteristic of delusional disorder.<xref ref-type="bibr" rid="article-20800.r35">[35]</xref></p>
      </sec>
      <sec id="article-20800.s10" sec-type="Pertinent Studies and Ongoing Trials">
        <title>Pertinent Studies and Ongoing Trials</title>
        <p>Psychopharmacology is the most readily available treatment vehicle for individuals seeking treatment for BDD, followed by psychotherapeutic interventions. However, both invasive and noninvasive neuromodulation interventions are known as effective treatments for various psychiatric disorders. Studies investigating neuromodulation interventions to treat BDD are minimal.<xref ref-type="bibr" rid="article-20800.r52">[52]</xref>&#x000a0;However, there are strong reasons to consider these modalities as potential future therapeutic options for BDD due to the success of deep brain stimulation in treating OCD. Deep brain stimulation requires neurosurgically implanting electrodes that send electrical stimulation to specified brain areas. The complete efficacy of deep brain stimulation for OCD is not established, but the results are promising.<xref ref-type="bibr" rid="article-20800.r53">[53]</xref>&#x000a0;Baldermann et al. reported a case of successful treatment for BDD with deep brain stimulation of the ventral capsule, or ventral striatum.<xref ref-type="bibr" rid="article-20800.r52">[52]</xref></p>
      </sec>
      <sec id="article-20800.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Patients receiving treatment for BDD, including medication, psychotherapy, or a combination of both, are estimated to have a treatment response between 50% and 80% within 4 to 16 weeks.<xref ref-type="bibr" rid="article-20800.r40">[40]</xref><xref ref-type="bibr" rid="article-20800.r37">[37]</xref><xref ref-type="bibr" rid="article-20800.r54">[54]</xref>&#x000a0;Maintenance treatment is recommended to prevent relapse, but the length of time for maintenance treatment is unclear.<xref ref-type="bibr" rid="article-20800.r54">[54]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-20800.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Suffering from BDD results in impaired performance in social relationships, emotional processing, and work and school performance.<xref ref-type="bibr" rid="article-20800.r55">[55]</xref>&#x000a0;Quality of life associated with BDD is poor.<xref ref-type="bibr" rid="article-20800.r56">[56]</xref>&#x000a0;Due to the potential for severe psychosocial impairment associated with BDD, the development of other comorbid psychiatric illnesses is common. Nearly 75% of patients with BDD also have major depressive disorder.<xref ref-type="bibr" rid="article-20800.r57">[57]</xref><xref ref-type="bibr" rid="article-20800.r58">[58]</xref>&#x000a0;Other common comorbidities are social anxiety disorder, substance use disorders, obsessive-compulsive disorder, any personality disorder, and eating disorders.<xref ref-type="bibr" rid="article-20800.r57">[57]</xref><xref ref-type="bibr" rid="article-20800.r58">[58]</xref></p>
        <p>The potential for suicidal thoughts and behavior is high. Suicidal ideation is present in nearly 50% of patients affected by BDD.<xref ref-type="bibr" rid="article-20800.r59">[59]</xref>.&#x000a0;Suicide attempts are estimated to occur in 1 out of 4 patients with BDD.<xref ref-type="bibr" rid="article-20800.r59">[59]</xref></p>
      </sec>
      <sec id="article-20800.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>Multiple American medical organizations have elected for BDD screenings in procedures that patients with BDD commonly seek. The American College of Obstetricians and Gynecologists recommends screening all adolescents seeking breast or labial surgery for BDD; further, consider screening adults seeking female genital cosmetic surgery when appropriate. The American Academy of Otolaryngology lists BDD as a contraindication for elective rhinoplasty, and patients seeking a rhinoplasty should be screened for BDD.&#x000a0;</p>
      </sec>
      <sec id="article-20800.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>BDD involves an overwhelming preoccupation with a perceived physical defect.&#x000a0;Typical areas of concern include the skin, hair, nose, genitalia, breasts, and body shape. These pervasive thoughts are persistent and difficult to control, causing emotional distress and consuming hours each day. Repetitive behaviors like checking oneself in the mirror, grooming, or reassurance-seeking are common attempts to ease the distress.</p>
        <p>The symptoms often go undetected and can severely impact one's life. Affected patients often seek cosmetic surgical solutions for their perceived defects. Unfortunately, surgical procedures are ineffective. With the help of a mental health professional, cognitive behavioral therapy, and possibly medications, many patients with BDD see improvement in their symptoms.</p>
      </sec>
      <sec id="article-20800.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Optimizing the healthcare professional and patient relationship is essential&#x000a0;when treating BDD, particularly for those with poor insight into their condition. Being mindful of the language and tone used during the clinical assessment can significantly impact rapport. Although some patients' perceived deficits might not be visible to others, avoiding the word "imagined" or similar is crucial, as this implies that the clinician believes the patient's symptoms are not real. Expressing empathy throughout the interview encourages patients to continue sharing their symptoms and allows for exploration of how the symptoms are impacting their lives. A careful balance is necessary to avoid minimizing the patient's perceived defect while at the same time not over-emphasizing or telling a patient that their perceived defect is visible if it is not.<xref ref-type="bibr" rid="article-20800.r40">[40]</xref>&#x000a0;Avoid arguments with the patient, particularly about the patient's physical appearance. Similar to delusional disorder, it is not helpful to attempt to correct a patient's false fixed belief through arguments; instead, optimize the treatment of the patient's psychiatric symptoms.<xref ref-type="bibr" rid="article-20800.r60">[60]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-20800.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>BDD is a psychiatric condition marked by a fixation on perceived physical defects, contrary to others' observations. Often undetected, it leads to distress and repetitive actions, potentially escalating to suicidal tendencies. BDD patients may seek unnecessary cosmetic procedures. Understanding diagnostic criteria and implementing evidence-based approaches is crucial across healthcare specialties, given the disorder's underrecognition. Neuroanatomic findings and altered visual processing characterize BDD, contributing to emotional processing deficits and executive function impairment. Screening tools and direct inquiry aid recognition, prompting referral for psychiatric evaluation. Treatment involves psychotherapeutic interventions, primarily cognitive-behavioral therapy, and pharmacotherapy, focusing on selective serotonin reuptake inhibitors and, if necessary, tricyclic antidepressants. Suicidal risk necessitates inpatient care.</p>
        <p>An essential component of successfully managing BDD is readily recognizing its clinical presentation. Individuals are more likely to first present to clinicians outside of psychiatry. Dermatology, plastic surgery, primary care, and dentistry healthcare professionals must assist&#x000a0;with diagnosis by&#x000a0;first screening and identifying BDD. Subsequently, clinicians should make appropriate referrals to psychiatric healthcare professionals and collaborate with both the psychiatric clinician and the psychologist to develop a comprehensive treatment plan.<xref ref-type="bibr" rid="article-20800.r61">[61]</xref>&#x000a0;Because insight may be poor in BDD, optimizing the therapeutic relationship is essential in helping patients adhere to their treatment plan.&#x000a0;</p>
      </sec>
      <sec id="article-20800.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20800&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20800">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/mental-health/body-dysmorphic-disorder/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20800">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20800/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20800">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-20800.s18">
        <title>References</title>
        <ref id="article-20800.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fran&#x000e7;a</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Roccia</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Castillo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>ALHarbi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tchernev</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chokoeva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lotti</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fioranelli</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Body dysmorphic disorder: history and curiosities.</article-title>
            <source>Wien Med Wochenschr</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>167</volume>
            <issue>Suppl 1</issue>
            <fpage>5</fpage>
            <page-range>5-7</page-range>
            <pub-id pub-id-type="pmid">28220373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Wilhelm</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Koran</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Didie</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Fallon</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Feusner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Body dysmorphic disorder: some key issues for DSM-V.</article-title>
            <source>Depress Anxiety</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>573</fpage>
            <page-range>573-91</page-range>
            <pub-id pub-id-type="pmid">20533368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Veale</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gledhill</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Christodoulou</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hodsoll</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Body dysmorphic disorder in different settings: A systematic review and estimated weighted prevalence.</article-title>
            <source>Body Image</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>18</volume>
            <fpage>168</fpage>
            <page-range>168-86</page-range>
            <pub-id pub-id-type="pmid">27498379</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Kaye</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>The relationship of body dysmorphic disorder and eating disorders to obsessive-compulsive disorder.</article-title>
            <source>CNS Spectr</source>
            <year>2007</year>
            <month>May</month>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>347</fpage>
            <page-range>347-58</page-range>
            <pub-id pub-id-type="pmid">17514080</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Monzani</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rijsdijk</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mataix-Cols</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The structure of genetic and environmental risk factors for dimensional representations of DSM-5 obsessive-compulsive spectrum disorders.</article-title>
            <source>JAMA Psychiatry</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>71</volume>
            <issue>2</issue>
            <fpage>182</fpage>
            <page-range>182-9</page-range>
            <pub-id pub-id-type="pmid">24369376</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neziroglu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Khemlani-Patel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yaryura-Tobias</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Rates of abuse in body dysmorphic disorder and obsessive-compulsive disorder.</article-title>
            <source>Body Image</source>
            <year>2006</year>
            <month>Jun</month>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>189</fpage>
            <page-range>189-93</page-range>
            <pub-id pub-id-type="pmid">18089222</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Didie</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Tortolani</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Pope</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Menard</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Fay</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Childhood abuse and neglect in body dysmorphic disorder.</article-title>
            <source>Child Abuse Negl</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>30</volume>
            <issue>10</issue>
            <fpage>1105</fpage>
            <page-range>1105-15</page-range>
            <pub-id pub-id-type="pmid">17005251</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buhlmann</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Glaesmer</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mewes</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fama</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Wilhelm</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Br&#x000e4;hler</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rief</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Updates on the prevalence of body dysmorphic disorder: a population-based survey.</article-title>
            <source>Psychiatry Res</source>
            <year>2010</year>
            <month>Jun</month>
            <day>30</day>
            <volume>178</volume>
            <issue>1</issue>
            <fpage>171</fpage>
            <page-range>171-5</page-range>
            <pub-id pub-id-type="pmid">20452057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Veale</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bewley</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Body dysmorphic disorder.</article-title>
            <source>BMJ</source>
            <year>2015</year>
            <month>Jun</month>
            <day>18</day>
            <volume>350</volume>
            <fpage>h2278</fpage>
            <pub-id pub-id-type="pmid">26088615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schieber</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kollei</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>de Zwaan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Classification of body dysmorphic disorder - what is the advantage of the new DSM-5 criteria?</article-title>
            <source>J Psychosom Res</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>78</volume>
            <issue>3</issue>
            <fpage>223</fpage>
            <page-range>223-7</page-range>
            <pub-id pub-id-type="pmid">25595027</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M&#x000f6;llmann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dietel</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Hunger</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Buhlmann</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of body dysmorphic disorder and associated features in German adolescents: A self-report survey.</article-title>
            <source>Psychiatry Res</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>254</volume>
            <fpage>263</fpage>
            <page-range>263-267</page-range>
            <pub-id pub-id-type="pmid">28482195</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schneider</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Mond</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Hudson</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Sex Differences in the Presentation of Body Dysmorphic Disorder in a Community Sample of Adolescents.</article-title>
            <source>J Clin Child Adolesc Psychol</source>
            <year>2019</year>
            <season>May-Jun</season>
            <volume>48</volume>
            <issue>3</issue>
            <fpage>516</fpage>
            <page-range>516-528</page-range>
            <pub-id pub-id-type="pmid">28541768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leggat</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Medical tourism.</article-title>
            <source>Aust Fam Physician</source>
            <year>2015</year>
            <season>Jan-Feb</season>
            <volume>44</volume>
            <issue>1-2</issue>
            <fpage>16</fpage>
            <page-range>16-21</page-range>
            <pub-id pub-id-type="pmid">25688954</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feusner</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Townsend</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bystritsky</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McKinley</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moller</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bookheimer</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Regional brain volumes and symptom severity in body dysmorphic disorder.</article-title>
            <source>Psychiatry Res</source>
            <year>2009</year>
            <month>May</month>
            <day>15</day>
            <volume>172</volume>
            <issue>2</issue>
            <fpage>161</fpage>
            <page-range>161-7</page-range>
            <pub-id pub-id-type="pmid">19328661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rauch</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Segal</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Makris</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Whalen</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Jenike</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Caviness</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>DN</given-names>
              </name>
            </person-group>
            <article-title>A preliminary morphometric magnetic resonance imaging study of regional brain volumes in body dysmorphic disorder.</article-title>
            <source>Psychiatry Res</source>
            <year>2003</year>
            <month>Jan</month>
            <day>20</day>
            <volume>122</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-9</page-range>
            <pub-id pub-id-type="pmid">12589879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Atmaca</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bingol</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Aydin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yildirim</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Okur</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Yildirim</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Mermi</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Gurok</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Brain morphology of patients with body dysmorphic disorder.</article-title>
            <source>J Affect Disord</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>123</volume>
            <issue>1-3</issue>
            <fpage>258</fpage>
            <page-range>258-63</page-range>
            <pub-id pub-id-type="pmid">19846221</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feusner</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Arienzo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zhan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gadelkarim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Leow</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>White matter microstructure in body dysmorphic disorder and its clinical correlates.</article-title>
            <source>Psychiatry Res</source>
            <year>2013</year>
            <month>Feb</month>
            <day>28</day>
            <volume>211</volume>
            <issue>2</issue>
            <fpage>132</fpage>
            <page-range>132-40</page-range>
            <pub-id pub-id-type="pmid">23375265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beilharz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Castle</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Grace</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rossell</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>A systematic review of visual processing and associated treatments in body dysmorphic disorder.</article-title>
            <source>Acta Psychiatr Scand</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>136</volume>
            <issue>1</issue>
            <fpage>16</fpage>
            <page-range>16-36</page-range>
            <pub-id pub-id-type="pmid">28190269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feusner</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Townsend</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bystritsky</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bookheimer</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Visual information processing of faces in body dysmorphic disorder.</article-title>
            <source>Arch Gen Psychiatry</source>
            <year>2007</year>
            <month>Dec</month>
            <volume>64</volume>
            <issue>12</issue>
            <fpage>1417</fpage>
            <page-range>1417-25</page-range>
            <pub-id pub-id-type="pmid">18056550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feusner</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Hembacher</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Moller</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Moody</surname>
                <given-names>TD</given-names>
              </name>
            </person-group>
            <article-title>Abnormalities of object visual processing in body dysmorphic disorder.</article-title>
            <source>Psychol Med</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>41</volume>
            <issue>11</issue>
            <fpage>2385</fpage>
            <page-range>2385-97</page-range>
            <pub-id pub-id-type="pmid">21557897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feusner</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Moody</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hembacher</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Townsend</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McKinley</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moller</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bookheimer</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Abnormalities of visual processing and frontostriatal systems in body dysmorphic disorder.</article-title>
            <source>Arch Gen Psychiatry</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>197</fpage>
            <page-range>197-205</page-range>
            <pub-id pub-id-type="pmid">20124119</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moody</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Morfini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sheen</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Kerr</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Strober</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Feusner</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Brain activation and connectivity in anorexia nervosa and body dysmorphic disorder when viewing bodies: relationships to clinical symptoms and perception of appearance.</article-title>
            <source>Brain Imaging Behav</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>1235</fpage>
            <page-range>1235-1252</page-range>
            <pub-id pub-id-type="pmid">32875486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buhlmann</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Etcoff</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Wilhelm</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Emotion recognition bias for contempt and anger in body dysmorphic disorder.</article-title>
            <source>J Psychiatr Res</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>105</fpage>
            <page-range>105-11</page-range>
            <pub-id pub-id-type="pmid">15904932</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanes</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Neuropsychological performance in body dysmorphic disorder.</article-title>
            <source>J Int Neuropsychol Soc</source>
            <year>1998</year>
            <month>Mar</month>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>167</fpage>
            <page-range>167-71</page-range>
            <pub-id pub-id-type="pmid">9529826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deckersbach</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Savage</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Wilhelm</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Buhlmann</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Rauch</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Baer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jenike</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Characteristics of memory dysfunction in body dysmorphic disorder.</article-title>
            <source>J Int Neuropsychol Soc</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>6</volume>
            <issue>6</issue>
            <fpage>673</fpage>
            <page-range>673-81</page-range>
            <pub-id pub-id-type="pmid">11011514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dunai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Labuschagne</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Castle</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Kyrios</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rossell</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Executive function in body dysmorphic disorder.</article-title>
            <source>Psychol Med</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>40</volume>
            <issue>9</issue>
            <fpage>1541</fpage>
            <page-range>1541-8</page-range>
            <pub-id pub-id-type="pmid">19951448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilhelm</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Rosenfield</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kasarskis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Blashill</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>The Body Dysmorphic Disorder Symptom Scale: Development and preliminary validation of a self-report scale of symptom specific dysfunction.</article-title>
            <source>Body Image</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>17</volume>
            <fpage>82</fpage>
            <page-range>82-7</page-range>
            <pub-id pub-id-type="pmid">26971118</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Picavet</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gabri&#x000eb;ls</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jorissen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hellings</surname>
                <given-names>PW</given-names>
              </name>
            </person-group>
            <article-title>Screening tools for body dysmorphic disorder in a cosmetic surgery setting.</article-title>
            <source>Laryngoscope</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>121</volume>
            <issue>12</issue>
            <fpage>2535</fpage>
            <page-range>2535-41</page-range>
            <pub-id pub-id-type="pmid">22109751</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hollander</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Aronowitz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schmeidler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Simeon</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness.</article-title>
            <source>Arch Gen Psychiatry</source>
            <year>1999</year>
            <month>Nov</month>
            <volume>56</volume>
            <issue>11</issue>
            <fpage>1033</fpage>
            <page-range>1033-9</page-range>
            <pub-id pub-id-type="pmid">10565503</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillipou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rossell</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Wilding</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Castle</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Randomised controlled trials of psychological &#x00026; pharmacological treatments for body dysmorphic disorder: A systematic review.</article-title>
            <source>Psychiatry Res</source>
            <year>2016</year>
            <month>Nov</month>
            <day>30</day>
            <volume>245</volume>
            <fpage>179</fpage>
            <page-range>179-185</page-range>
            <pub-id pub-id-type="pmid">27544783</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Storch</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Mariaskin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>TK</given-names>
              </name>
            </person-group>
            <article-title>Psychotherapy for obsessive-compulsive disorder.</article-title>
            <source>Curr Psychiatry Rep</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>296</fpage>
            <page-range>296-301</page-range>
            <pub-id pub-id-type="pmid">19635238</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crerand</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Menard</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Fay</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Nonpsychiatric medical treatment of body dysmorphic disorder.</article-title>
            <source>Psychosomatics</source>
            <year>2005</year>
            <season>Nov-Dec</season>
            <volume>46</volume>
            <issue>6</issue>
            <fpage>549</fpage>
            <page-range>549-55</page-range>
            <pub-id pub-id-type="pmid">16288134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harrison</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez de la Cruz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Enander</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Radua</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mataix-Cols</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Cognitive-behavioral therapy for body dysmorphic disorder: A systematic review and meta-analysis of randomized controlled trials.</article-title>
            <source>Clin Psychol Rev</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>48</volume>
            <fpage>43</fpage>
            <page-range>43-51</page-range>
            <pub-id pub-id-type="pmid">27393916</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Enander</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Andersson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mataix-Cols</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lichtenstein</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Alstr&#x000f6;m</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Andersson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lj&#x000f3;tsson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>R&#x000fc;ck</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Therapist guided internet based cognitive behavioural therapy for body dysmorphic disorder: single blind randomised controlled trial.</article-title>
            <source>BMJ</source>
            <year>2016</year>
            <month>Feb</month>
            <day>02</day>
            <volume>352</volume>
            <fpage>i241</fpage>
            <pub-id pub-id-type="pmid">26837684</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buhlmann</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Reese</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Renaud</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wilhelm</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical considerations for the treatment of body dysmorphic disorder with cognitive-behavioral therapy.</article-title>
            <source>Body Image</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-49</page-range>
            <pub-id pub-id-type="pmid">18313372</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Albertini</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.</article-title>
            <source>Arch Gen Psychiatry</source>
            <year>2002</year>
            <month>Apr</month>
            <volume>59</volume>
            <issue>4</issue>
            <fpage>381</fpage>
            <page-range>381-8</page-range>
            <pub-id pub-id-type="pmid">11926939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Pharmacotherapy for Body Dysmorphic Disorder.</article-title>
            <source>Psychiatr Ann</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>40</volume>
            <issue>7</issue>
            <fpage>325</fpage>
            <page-range>325-332</page-range>
            <pub-id pub-id-type="pmid">27761054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baumgarten</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Grozdanovic</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Role of serotonin in obsessive-compulsive disorder.</article-title>
            <source>Br J Psychiatry Suppl</source>
            <year>1998</year>
            <issue>35</issue>
            <fpage>13</fpage>
            <page-range>13-20</page-range>
            <pub-id pub-id-type="pmid">9829022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cooke</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Waring</surname>
                <given-names>WS</given-names>
              </name>
            </person-group>
            <article-title>Citalopram and cardiac toxicity.</article-title>
            <source>Eur J Clin Pharmacol</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>69</volume>
            <issue>4</issue>
            <fpage>755</fpage>
            <page-range>755-60</page-range>
            <pub-id pub-id-type="pmid">22996077</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Hollander</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach.</article-title>
            <source>Body Image</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-27</page-range>
            <pub-id pub-id-type="pmid">18325859</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Albertini</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Siniscalchi</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study.</article-title>
            <source>J Clin Psychiatry</source>
            <year>2001</year>
            <month>Sep</month>
            <volume>62</volume>
            <issue>9</issue>
            <fpage>721</fpage>
            <page-range>721-7</page-range>
            <pub-id pub-id-type="pmid">11681769</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>An open study of buspirone augmentation of serotonin-reuptake inhibitors in body dysmorphic disorder.</article-title>
            <source>Psychopharmacol Bull</source>
            <year>1996</year>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>175</fpage>
            <page-range>175-80</page-range>
            <pub-id pub-id-type="pmid">8927669</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakaaki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Murata</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Furukawa</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder.</article-title>
            <source>Psychiatry Clin Neurosci</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>370</fpage>
            <pub-id pub-id-type="pmid">18588607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Uzun</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Ozdemir</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Aripiprazole as an augmentation agent in treatment-resistant body dysmorphic disorder.</article-title>
            <source>Clin Drug Investig</source>
            <year>2010</year>
            <volume>30</volume>
            <issue>10</issue>
            <fpage>707</fpage>
            <page-range>707-10</page-range>
            <pub-id pub-id-type="pmid">20701402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hadley</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Simeon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Friedberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Priday</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Hollander</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>An open-label trial of venlafaxine in body dysmorphic disorder.</article-title>
            <source>CNS Spectr</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>138</fpage>
            <page-range>138-44</page-range>
            <pub-id pub-id-type="pmid">18227745</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nardi</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Lopes</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Valen&#x000e7;a</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Body dysmorphic disorder treated with bupropion: cases report.</article-title>
            <source>Aust N Z J Psychiatry</source>
            <year>2005</year>
            <season>Jan-Feb</season>
            <volume>39</volume>
            <issue>1-2</issue>
            <fpage>112</fpage>
            <pub-id pub-id-type="pmid">15660717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Canan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sinani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Aydinoglu</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Body dysmorphic disorder incidentally treated with bupropion: a case report.</article-title>
            <source>J Clin Psychopharmacol</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>133</fpage>
            <page-range>133-4</page-range>
            <pub-id pub-id-type="pmid">23288237</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Pinto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Coles</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Eisen</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Menard</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>A comparison of insight in body dysmorphic disorder and obsessive-compulsive disorder.</article-title>
            <source>J Psychiatr Res</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>46</volume>
            <issue>10</issue>
            <fpage>1293</fpage>
            <page-range>1293-9</page-range>
            <pub-id pub-id-type="pmid">22819678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Pinto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Menard</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Eisen</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Mancebo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Obsessive-compulsive disorder versus body dysmorphic disorder: a comparison study of two possibly related disorders.</article-title>
            <source>Depress Anxiety</source>
            <year>2007</year>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>399</fpage>
            <page-range>399-409</page-range>
            <pub-id pub-id-type="pmid">17041935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fr&#x000ed;as</surname>
                <given-names>&#x000c1;</given-names>
              </name>
              <name>
                <surname>Palma</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Farriols</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Comorbidity between obsessive-compulsive disorder and body dysmorphic disorder: prevalence, explanatory theories, and clinical characterization.</article-title>
            <source>Neuropsychiatr Dis Treat</source>
            <year>2015</year>
            <volume>11</volume>
            <fpage>2233</fpage>
            <page-range>2233-44</page-range>
            <pub-id pub-id-type="pmid">26345330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dhejne</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Van Vlerken</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Heylens</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Arcelus</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Mental health and gender dysphoria: A review of the literature.</article-title>
            <source>Int Rev Psychiatry</source>
            <year>2016</year>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>44</fpage>
            <page-range>44-57</page-range>
            <pub-id pub-id-type="pmid">26835611</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baldermann</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Kohl</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Visser-Vandewalle</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Klehr</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Huys</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kuhn</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum Reproducibly Improves Symptoms of Body Dysmorphic Disorder.</article-title>
            <source>Brain Stimul</source>
            <year>2016</year>
            <season>Nov-Dec</season>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>957</fpage>
            <page-range>957-959</page-range>
            <pub-id pub-id-type="pmid">27743837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martinho</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Duarte</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Couto</surname>
                <given-names>FSD</given-names>
              </name>
            </person-group>
            <article-title>Efficacy, Effect on Mood Symptoms, and Safety of Deep Brain Stimulation in Refractory Obsessive-Compulsive Disorder: A Systematic Review and Meta-Analysis.</article-title>
            <source>J Clin Psychiatry</source>
            <year>2020</year>
            <month>May</month>
            <day>26</day>
            <volume>81</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">32459406</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Keshaviah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dougherty</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Stout</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Menard</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wilhelm</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled Trial.</article-title>
            <source>Am J Psychiatry</source>
            <year>2016</year>
            <month>Sep</month>
            <day>01</day>
            <volume>173</volume>
            <issue>9</issue>
            <fpage>887</fpage>
            <page-range>887-95</page-range>
            <pub-id pub-id-type="pmid">27056606</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>IsHak</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Bolton</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Bensoussan</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Dous</surname>
                <given-names>GV</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Powell-Hicks</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Gardner</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Ponton</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Quality of life in body dysmorphic disorder.</article-title>
            <source>CNS Spectr</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>167</fpage>
            <page-range>167-75</page-range>
            <pub-id pub-id-type="pmid">22939280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Menard</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Fay</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pagano</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Psychosocial functioning and quality of life in body dysmorphic disorder.</article-title>
            <source>Compr Psychiatry</source>
            <year>2005</year>
            <season>Jul-Aug</season>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>254</fpage>
            <page-range>254-60</page-range>
            <pub-id pub-id-type="pmid">16175755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gunstad</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Axis I comorbidity in body dysmorphic disorder.</article-title>
            <source>Compr Psychiatry</source>
            <year>2003</year>
            <season>Jul-Aug</season>
            <volume>44</volume>
            <issue>4</issue>
            <fpage>270</fpage>
            <page-range>270-6</page-range>
            <pub-id pub-id-type="pmid">12923704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Menard</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Fay</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Weisberg</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder.</article-title>
            <source>Psychosomatics</source>
            <year>2005</year>
            <season>Jul-Aug</season>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>317</fpage>
            <page-range>317-25</page-range>
            <pub-id pub-id-type="pmid">16000674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Angelakis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gooding</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Panagioti</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Suicidality in body dysmorphic disorder (BDD): A systematic review with meta-analysis.</article-title>
            <source>Clin Psychol Rev</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>49</volume>
            <fpage>55</fpage>
            <page-range>55-66</page-range>
            <pub-id pub-id-type="pmid">27607741</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hylwa</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Bury</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Pittelkow</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Bostwick</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Delusional infestation is typically comorbid with other psychiatric diagnoses: review of 54 patients receiving psychiatric evaluation at Mayo Clinic.</article-title>
            <source>Psychosomatics</source>
            <year>2012</year>
            <season>May-Jun</season>
            <volume>53</volume>
            <issue>3</issue>
            <fpage>258</fpage>
            <page-range>258-65</page-range>
            <pub-id pub-id-type="pmid">22458994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20800.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bouman</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Mulkens</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>van der Lei</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Cosmetic Professionals' Awareness of Body Dysmorphic Disorder.</article-title>
            <source>Plast Reconstr Surg</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>139</volume>
            <issue>2</issue>
            <fpage>336</fpage>
            <page-range>336-342</page-range>
            <pub-id pub-id-type="pmid">28121864</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
